FDA Requests Nominations for Drug Compounding List
President Obama signed the Drug Quality and Security Act (“DQSA”) into law on November 27, 2013. The DQSA contained provisions concerning the oversight of human drug compounding. For instance, it removed provisions of section 503A of the federal Food, Drug, and Cosmetic Act (“FDCA”) that the U.S. Supreme Court previously held were unconstitutional, thereby ensuring […]